State legislators issued a critical report Thursday on the proposed $2.5 billion sale of Blue Cross and Blue Shield of Louisiana to Indiana-based Elevance Health, questioning the fairness of the deal’s regulatory and voting process, among other issues, on the same day that Louisiana’s powerful hospital association voiced its own opposition.